XFOR
#3075
X4 Pharmaceuticals, Inc. - Common Stock
4.0 5 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.26%
Variación mensual
+3.05%
Variación en los últimos 6 meses
+22.17%
Cambio anual
+36.36%
Cierres anteriores
4.2 3
Open
4.0 3
Mínimo
4.0 0
Máximo
4.0 6
Volumen
273
Financials
- Market Capitalization 401.54 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.14
Relación precio/flujo de caja
26.03
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3051 |  LRMR Larimar Therapeutics, Inc. - Common Stock | 4.00 USD | -1.23% | -4.31% | +4.99% | +2.04% | 415.53 M USD | ||
| 3061 |  GALT Galectin Therapeutics Inc. - Common Stock | 4.03 USD | -2.66% | +9.51% | +17.49% | -4.05% | 406.42 M USD | ||
| 3076 |  CTNM Contineum Therapeutics, Inc. - Common stock | 17.00 USD | -1.45% | -1.11% | +19.97% | +11.33% | 392.69 M USD | ||
| 3088 |  ENTA Enanta Pharmaceuticals, Inc. - Common Stock | 13.65 USD | -1.09% | +1.34% | +8.68% | +57.08% | 397.56 M USD |